U.S. markets close in 22 minutes

Ra Medical Systems, Inc. (RMED)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
7.69-0.11 (-1.41%)
As of 3:38PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Performance Outlook
Previous Close7.80
Open7.95
Bid7.75 x 1400
Ask7.82 x 1000
Day's Range7.18 - 8.15
52 Week Range4.25 - 42.00
Volume403,007
Avg. Volume372,762
Market Cap24.789M
Beta (5Y Monthly)1.63
PE Ratio (TTM)N/A
EPS (TTM)-31.89
Earnings DateNov 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Business Wire

    Ra Medical Systems Appoints Susanne L. Meline to its Board of Directors

    Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Susanne L. Meline to its Board of Directors, effective January 31, 2021. Her appointment expands Board membership to seven.

  • Business Wire

    Ra Medical Systems Reports Progress with Extending DABRA Catheter Shelf Life, Completes Quality Improvement Plan

    Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports progress with extending the shelf life of its more robust, next generation DABRA catheter, featuring a braided overjacket to improve deliverability when navigating tortuous anatomy. The Company also announces completion of all 116 items identified in a quality improvement plan that stemmed from an internal audit in late 2019, with enhancements to standard operating procedures, preventive maintenance, equipment status, and calibrations and supplier quality.

  • Business Wire

    Ra Medical Systems to Present at H.C. Wainwright Virtual BioConnect Conference

    Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will present at the H.C. Wainwright Virtual BioConnect Conference.